Evidence-based guideline: Management of an unprovoked first seizure in adults
Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society
Citation Manager Formats
Make Comment
See Comments

Abstract
Objective: To provide evidence-based recommendations for treatment of adults with an unprovoked first seizure.
Methods: We defined relevant questions and systematically reviewed published studies according to the American Academy of Neurology's classification of evidence criteria; we based recommendations on evidence level.
Results and recommendations: Adults with an unprovoked first seizure should be informed that their seizure recurrence risk is greatest early within the first 2 years (21%–45%) (Level A), and clinical variables associated with increased risk may include a prior brain insult (Level A), an EEG with epileptiform abnormalities (Level A), a significant brain-imaging abnormality (Level B), and a nocturnal seizure (Level B). Immediate antiepileptic drug (AED) therapy, as compared with delay of treatment pending a second seizure, is likely to reduce recurrence risk within the first 2 years (Level B) but may not improve quality of life (Level C). Over a longer term (>3 years), immediate AED treatment is unlikely to improve prognosis as measured by sustained seizure remission (Level B). Patients should be advised that risk of AED adverse events (AEs) may range from 7% to 31% (Level B) and that these AEs are likely predominantly mild and reversible. Clinicians' recommendations whether to initiate immediate AED treatment after a first seizure should be based on individualized assessments that weigh the risk of recurrence against the AEs of AED therapy, consider educated patient preferences, and advise that immediate treatment will not improve the long-term prognosis for seizure remission but will reduce seizure risk over the subsequent 2 years.
GLOSSARY
- AAN=
- American Academy of Neurology;
- AE=
- adverse event;
- AED=
- antiepileptic drug;
- CI=
- confidence interval;
- ILAE=
- International League Against Epilepsy;
- QOL=
- quality of life
Footnotes
Approved by the Guideline Development Subcommittee on November 16, 2013; by the Practice Committee on January 20, 2014; by the AES Board of Directors on February 13, 2014; and by the AANI Board of Directors on December 1, 2014.
This guideline was endorsed by the World Federation of Neurology on May 20, 2014, and by the American Neurological Association on May 21, 2014.
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received March 10, 2014.
- Accepted in final form October 30, 2014.
- © 2015 American Academy of Neurology
Letters: Rapid online correspondence
- Commentary authors' response to Krumholz
- Andrew J. Cole, Massachusetts General Hospital and Harvard Medical School, Boston;cole.andrew@mgh.harvard.edu
- Gregory D. Cascino, Mayo Clinic, Rochester, MN
Submitted July 14, 2015 - Guideline authors' response to Neurology: Clinical Practice commentary by Drs. Cole and Cascino
- Allan Krumholz, Director, US Department of Veterans Affairs Maryland Healthcare System Epilepsy Center of Excellenceguidelines@aan.com
- Allan Krumholz, Baltimore, MD; Shlomo Shinnar, Bronx, NY; Jacqueline French, New York, NY; Gary Gronseth, Kansas City, KS; Samuel Wiebe, Calgary, Alberta, Canada
Submitted July 14, 2015 - The management of an unprovoked first seizure in adults
- Simona Lattanzi, MD, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Ancona, Italy.alfierelattanzisimona@gmail.com
- Claudia Cagnetti, Mauro Silvestrini, Ancona, Italy
Submitted July 07, 2015 - Authors' response to Dr. Lattanzi et al.
- Allan Krumholz, Director, US Department of Veterans Affairs Maryland Healthcare System Epilepsy Center of Excellenceguidelines@aan.com
- Allan Krumholz, Baltimore, MD; Shlomo Shinnar, Bronx, NY; Jacqueline French, New York, NY; Samuel Wiebe, Calgary, Alberta, Canada; David Gloss, Danville, PA
Submitted June 03, 2015 - Authors' response to Dr. Sethi's correspondence
- Allan Krumholz, MD, Director, US Department of Veterans Affairs Maryland Healthcare System Epilepsy Center of Excellenceguidelines@aan.com
- Shlomo Shinnar, MD, PhD, Bronx, NY; Jacqueline French, MD, New York, NY; David S. Gloss, MD, Danville, PA; Samuel Wiebe, MD, Calgary, Alberta, Canada
Submitted May 08, 2015 - Unprovoked first seizure: to treat or not to treat?
- Nitin K. Sethi, Assistant Professor of Neurology, New York-Presbyterian Hospital, Weill Cornell Medical Center 525 East 68th Street, New York, NY 1006sethinitinmd@hotmail.com
- Nitin K Sethi, New York, NY
Submitted May 01, 2015
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan